Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Complexities in Antifungal Pharmacotherapy: A Comprehensive Pharmacovigilance Analysis
*Corresponding Author:Received Date: May 24, 2024 / Published Date: Jun 11, 2025
Citation: Chaurasia A (2025) Complexities in Antifungal Pharmacotherapy: A Comprehensive Pharmacovigilance Analysis. Int J Res Dev Pharm L Sci 11: 275.
Copyright: © 2025 Chaurasia A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
This project report provides a comprehensive overview of the pharmacovigilance of antifungal drugs, focusing on regulatory considerations, risk management strategies, key findings from pharmacovigilance reports and future directions in antifungal therapy. The report highlights the importance of continuous monitoring and assessment of antifungal drugs to ensure their safe and effective use. Key findings include the increased risk of gastrointestinal adverse effects, hepatotoxicity, renal impairment, allergic reactions and potential drug interactions associated with antifungal drugs. Recommendations for safe use include adherence to recommended dosages, limitation of prolonged use, awareness of potential adverse effects, individualized risk assessment and patient education. The report concludes with a call for ongoing surveillance, research and development of novel antifungal agents to address evolving challenges in antifungal therapy and ensure patient safety.
